The PaceNew therapies / indications available since the last 12 months 
Jublia
BY: Olive TseMar 16, 2020

Jublia

(efinaconazole) Main Life

 

Composition:

• Available in topical solution with each contains 10% w/w of efinaconazole

 

Indication:

• Indicated for the topical treatment of onychomycosis (tinea unguium) of the toenails due to Trichophyton rubrum and Trichophyton mentagrophytes

 

Drug information including formulation, indication, administration and/or presentation updated, registered or launched in Hong Kong within one year prior to the date written is regarded as new in The Pace.

The information in The Pace is provided as a courtesy service to our readers and is intended for medical professional reference only. Please peruse the latest local prescription information prior to prescription.

You May Be Interested In
Maviret
BY: Olive TseMar 16, 2020
Darzalex
BY: Winnie TangDec 22, 2022
ANAGRELIDE SANDOZ®
BY: Dr. Mohsin RoshanOct 22, 2024
Imbruvica®
BY: Jasper ChanJun 16, 2015